UFPT earnings analysis
What we found in UFPT's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
UFP Technologies reported Q1 2026 net sales of $154.2 million, a 4.1% increase compared to Q1 2025, primarily driven by a 5.9% increase in medical segment sales. Gross margin improved slightly to 28.8%, while diluted EPS increased to $2.24, surpassing estimates.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Revenue Growth
- Q1 2026 revenue increased to $154.2 million, up 4.1% from $148.1 million in Q1 2025.
- EPS Beat
- Diluted EPS rose to $2.24, exceeding the estimated EPS of $2.28.
- Medical Segment Performance
- Medical sales grew 5.9% to $143.4 million, highlighting strong demand.
- Margin Improvement
- Gross margin slightly improved to 28.8% from 28.5% in Q1 2025.
- Operating Cash Flow
- Operating cash flow was $3.2 million, reflecting solid profitability despite working capital changes.
- Decreased Interest Expense
- Net interest expense decreased to $1.7 million from $2.8 million due to lower average debt.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Labor Efficiency Issues
- Significant employee turnover at AJR due to E-Verify audits has decreased productivity.
- Customer Concentration Risk
- Two customers contributed 46.9% of revenue, raising dependence concerns.
- Tariff Uncertainties
- While effects of tariffs have decreased, future impacts remain uncertain following tariff refund processes.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $2.24
- Gross margin
- 28.8%
- Segment
- Medical
- Segment
- Non-medical
What they said about what is next.
Outlook deferred to earnings press release / call.
The filing reads better than the one before it.
What came before.
- 10-K · February 27, 2026
- UFP Technologies reported full-year 2025 net sales of $602.8 million, up 19.5% year-over-year driven largely by acquisitions that contributed approximately $168.3 million; organic sales growth was 1.5%. Gross margin…
- 10-Q · November 7, 2025
- UFP Technologies reported Q3 net sales of $154.558 million (three months ended September 30, 2025), up versus the prior-year quarter, with diluted EPS essentially flat at $2.11. Gross margin compressed to 27.7% while…
- 10-Q · May 12, 2025
- UFP reported strong Q1 results with net sales of $148,148 (in thousands) vs $105,009 in Q1-2024 (+$43,139, +41.1%), operating income of $23,126 (in thousands) and diluted EPS of $2.21 (vs $1.64 prior year). Gross margin…
- 10-Q · May 10, 2024
- UFP Technologies reported Q1 net sales of $105,009,000 (up $7,256,000 or 7.4% vs. Q1 2023 $97,753,000) and diluted EPS of $1.64 (vs. $1.27 in Q1 2023). Operating income rose to $15,924,000 (operating margin 15.2%) and…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing UFPT makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever